Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities (Details)

v3.24.3
Accrued expenses and other current liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Accrued expenses and other current liabilities    
Accrued clinical and development expenditure $ 13,281 $ 12,351
Accrued employee expenses 11,276 13,226
VAT Payable   1,398
Other accrued expenditure 5,780 3,277
Other 1,167 51
Total $ 31,504 $ 30,303